NewLimit
NewLimit is creating epigenetic reprogramming medications to cure diseases with significant unmet medical needs.
Operating in biotechnology, clinical trials, health care based in San Francisco Bay Area, West Coast, Western US, NewLimit was founded in 2022.
As a business in biotechnology, clinical trials, health care, NewLimit is listed here with the public details available about it.
The company is recorded as being based in San Francisco Bay Area, West Coast, Western US.
Its current recorded stage is Series_A.
Recorded headcount: c_00011_00050 employees.
Total disclosed funding stands at about $40M.
| Sector | Biotechnology, Clinical Trials, Health Care |
|---|---|
| Headquarters | San Francisco Bay Area, West Coast, Western US |
| Founded | 2022 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $40,000,000 |
Website: www.newlimit.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account